115 related articles for article (PubMed ID: 2936333)
1. Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H.
Alsenz J; Schulz TF; Lambris JD; Sim RB; Dierich MP
Biochem J; 1985 Dec; 232(3):841-50. PubMed ID: 2936333
[TBL] [Abstract][Full Text] [Related]
2. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H.
Alsenz J; Lambris JD; Schulz TF; Dierich MP
Biochem J; 1984 Dec; 224(2):389-98. PubMed ID: 6240261
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against the complement control protein factor H (beta 1 H).
Sim E; Palmer MS; Puklavec M; Sim RB
Biosci Rep; 1983 Dec; 3(12):1119-31. PubMed ID: 6199050
[TBL] [Abstract][Full Text] [Related]
4. Mapping of the properdin-binding site in the third component of complement.
Lambris JD; Alsenz J; Schulz TF; Dierich MP
Biochem J; 1984 Jan; 217(1):323-6. PubMed ID: 6696726
[TBL] [Abstract][Full Text] [Related]
5. Tryptic digestion of human GPIIIa. Isolation and biochemical characterization of the 23 kDa N-terminal glycopeptide carrying the antigenic determinant for a monoclonal antibody (P37) which inhibits platelet aggregation.
Calvete JJ; Rivas G; Maruri M; Alvarez MV; McGregor JL; Hew CL; Gonzalez-Rodriguez J
Biochem J; 1988 Mar; 250(3):697-704. PubMed ID: 2455507
[TBL] [Abstract][Full Text] [Related]
6. Phylogeny of regulatory proteins of the complement system. Isolation and characterization of a C4b/C3b inhibitor and a cofactor from sand bass plasma.
Kaidoh T; Gigli I
J Immunol; 1989 Mar; 142(5):1605-13. PubMed ID: 2918226
[TBL] [Abstract][Full Text] [Related]
7. Purification and structural studies on the complement-system control protein beta 1H (Factor H).
Sim RB; DiScipio RG
Biochem J; 1982 Aug; 205(2):285-93. PubMed ID: 6215918
[TBL] [Abstract][Full Text] [Related]
8. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
Davis AE; Harrison RA; Lachmann PJ
J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
[TBL] [Abstract][Full Text] [Related]
9. [Localization of functionally important areas of the regulator protein factor H using monoclonal antibodies].
Schulz TF; Alsenz J; Dierich MP
Wien Klin Wochenschr; 1985 Mar; 97(5):248-52. PubMed ID: 2581372
[TBL] [Abstract][Full Text] [Related]
10. Human complement factor H: isolation of cDNA clones and partial cDNA sequence of the 38-kDa tryptic fragment containing the binding site for C3b.
Schulz TF; Schwäble W; Stanley KK; Weiss E; Dierich MP
Eur J Immunol; 1986 Nov; 16(11):1351-5. PubMed ID: 2946589
[TBL] [Abstract][Full Text] [Related]
11. Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement.
Koistinen V
Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):317-9. PubMed ID: 1533511
[TBL] [Abstract][Full Text] [Related]
12. Use of a high-efficiency expression vector to isolate cDNA clones for factor H and map their positions within the molecule.
Schulz TF; Schwäble W; Stanley KK; Dierich MP
Mol Immunol; 1986 Nov; 23(11):1243-8. PubMed ID: 2434839
[TBL] [Abstract][Full Text] [Related]
13. Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.
Layet S; Girma JP; Obert B; Peynaud-Debayle E; Bihoreau N; Meyer D
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):129-37. PubMed ID: 1531749
[TBL] [Abstract][Full Text] [Related]
14. Characterization of proteolytic fragments of the laminin-nidogen complex and their activity in ligand-binding assays.
Mann K; Deutzmann R; Timpl R
Eur J Biochem; 1988 Dec; 178(1):71-80. PubMed ID: 2462498
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of membrane bound C3bi, an intermediate of the third component of complement, to C3c and C3d-like fragments by crude leucocyte lysosomal lysates and purified leucocyte elastase.
Carlo JR; Spitznagel JK; Studer EJ; Conrad DH; Ruddy S
Immunology; 1981 Oct; 44(2):381-91. PubMed ID: 7028603
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity of proteolytic degradation products of human prostatic acid phosphatase.
Kuciel R; Mazurkiewicz A; Steuden I; Wasylewska E; Szkudlarek J; Dulińska J; Ostrowski WS
Acta Biochim Pol; 1988; 35(4):319-30. PubMed ID: 2470219
[TBL] [Abstract][Full Text] [Related]
17. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
Medicus RG; Melamed J; Arnaout MA
Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
[TBL] [Abstract][Full Text] [Related]
18. Human complement factor H: an additional gene product of 43 kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complement.
Misasi R; Huemer HP; Schwaeble W; Sölder E; Larcher C; Dierich MP
Eur J Immunol; 1989 Sep; 19(9):1765-8. PubMed ID: 2529127
[TBL] [Abstract][Full Text] [Related]
19. Third component of complement (C3): structural properties in relation to functions.
Bokisch VA; Dierich MP; Mūller-Eberhard HJ
Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
[TBL] [Abstract][Full Text] [Related]
20. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
